STOCK TITAN
  1. Home
  2. Sec-filings
  3. HIMS
  4. [Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Form 4: HIMS director awarded 3,656 RSUs vesting by June 15, 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Andrea Perez Garcia, identified as a Director of Hims & Hers Health, Inc. (HIMS), was granted 3,656 Restricted Stock Units (RSUs) with an indicated price of $0 on 08/06/2025. The Form 4 reports the award as a derivative security and shows 3,656 shares beneficially owned following the transaction, held in a direct ownership form.

The filing explains each RSU is a contingent right to receive one share of Class A Common Stock and that the RSUs will vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service. The Form 4 was signed by an attorney-in-fact on 08/08/2025.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine director equity grant of 3,656 RSUs reported on Form 4; no immediate cash exercise and vesting occurs in 2026.

The filing documents a standard equity-based compensation award to a company director recorded as 3,656 RSUs on 08/06/2025. The grant is shown with a $0 price and increases reported beneficial ownership to 3,656 shares (direct). The RSUs convert to Class A common stock upon vesting, which is scheduled for the earlier of the 2026 annual meeting or June 15, 2026, subject to continuous service. This is a routine disclosure under Section 16 and reflects compensation reporting rather than an open-market trading event.

TL;DR: Grant aligns director incentives via time- and service-based vesting ahead of the 2026 stockholder meeting.

The Form 4 confirms the reporting person is a Director and that the RSUs vest based on continued service or the occurrence of the 2026 annual meeting, indicating retention and alignment objectives typical of board compensation. The instrument is described as a contingent right to one share per RSU, and the filing was executed by an attorney-in-fact on 08/08/2025. From a governance perspective, the disclosure meets Section 16 reporting requirements and documents routine director equity awards.

Insider Perez Garcia Andrea G
Role Director
Type Security Shares Price Value
Grant/Award Restricted Stock Unit 3,656 $0.00 --
Holdings After Transaction: Restricted Stock Unit — 3,656 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Perez Garcia Andrea G
(Last) (First) (Middle)
2269 CHESTNUT STREET, #523
(Street)
SAN FRANCISCO CA 94123
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Unit (1) 08/06/2025 A 3,656 (1) (1) Class A Common Stock 3,656 $0 3,656 D
Explanation of Responses:
1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.
Remarks:
/s/ Alexandra Cotter Wilkins, Attorney-in-Fact 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did the HIMS Form 4 filed for Andrea Perez Garcia report?

The Form 4 reports a grant of 3,656 Restricted Stock Units (RSUs) to director Andrea Perez Garcia with a transaction date of 08/06/2025.

When do the RSUs for HIMS director Andrea Perez Garcia vest?

The RSUs vest on the earlier of the 2026 annual meeting of stockholders or June 15, 2026, subject to continuous service.

How many shares does the Form 4 show as beneficially owned after the transaction for HIMS (HIMS)?

The Form 4 shows 3,656 shares beneficially owned following the reported transaction, held in a direct ownership form.

What price is indicated for the RSU grant in the HIMS Form 4?

The filing indicates a price of $0 for the restricted stock units.

Who signed the Form 4 for the HIMS filing and when was it signed?

The Form 4 was signed by Alexandra Cotter Wilkins, Attorney-in-Fact on 08/08/2025.